Avoidable U.S. healthcare costs due to delayed treatment by disease 2012
This statistic depicts the estimated avoidable healthcare costs due to delayed evidence-based treatment practice in the United States in 2012, by disease. In that year, atrial fibrillation was estimated to create a total of 0.7 billion U.S. dollars in avoidable costs. Total avoidable delayed evidence-based treatment practice healthcare costs reached 39.5 billion U.S. dollars in that year. Expected increase in insurance coverage, chronic diseases, and an aging population may place further stresses on the need for proper medication use to prevent avoidable healthcare costs.
